Douglas E. Onsi

Insider Reports History

Entity
Individual
Location
C/O Tolerrx Inc, 300 Technology Square, Cambridge, MA
Signature
/s/ Douglas E. Onsi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas E. Onsi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LEAP THERAPEUTICS, INC. CEO,CFO,Pres.,GC,Treas.,&Sec., Director Common Stock 414K $1.18M $2.85 Jan 26, 2024 By HealthCare Ventures IX, L.P.
LEAP THERAPEUTICS, INC. CEO,CFO,Pres.,GC,Treas.,&Sec., Director Common Stock 73.6K $210K $2.85 Jan 26, 2024 Direct
LEAP THERAPEUTICS, INC. CEO,CFO,Pres.,GC,Treas.,&Sec., Director Restricted Stock Units 0 $0 $2.85 Jan 26, 2024 Direct
LEAP THERAPEUTICS, INC. CEO,CFO,Pres.,GC,Treas.,&Sec., Director Employee Stock Option (Right to Buy) 170K Oct 2, 2024 Direct
LEAP THERAPEUTICS, INC. CEO,CFO,Pres.,GC,Treas.,&Sec., Director Employee Stock Option (Right to Buy) 170K Jan 29, 2024 Direct

Insider Reports Filed by Douglas E. Onsi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LPTX LEAP THERAPEUTICS, INC. Oct 2, 2024 1 $0 4 Oct 4, 2024 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Jan 29, 2024 1 $0 4 Jan 31, 2024 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Jan 26, 2024 2 $0 4 Jan 30, 2024 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Aug 23, 2023 1 $0 4 Aug 25, 2023 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Mar 31, 2023 1 $0 4 Apr 4, 2023 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Mar 17, 2023 2 $0 4 Mar 21, 2023 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Sep 1, 2022 1 $0 4 Sep 2, 2022 CEO,CFO,Pres.,GC,Treas.,&Sec., Director
LPTX LEAP THERAPEUTICS, INC. Jan 31, 2022 1 $0 4 Feb 2, 2022 CEO,CFO,Pres.,GC,Treas.,&Sec., Director, 10%+ Owner
LPTX LEAP THERAPEUTICS, INC. May 26, 2021 1 $0 4 May 28, 2021 CEO,CFO,Pres.,GC,Treas.,&Sec., Director, 10%+ Owner